References
- Ree IMC, Besuden CFJ, Wintjens V, et al. Exchange transfusions in severe Rh-mediated alloimmune haemolytic disease of the foetus and newborn: a 20-year overview on the incidence, associated risks and outcome. Vox Sang 2021;116:990–7.
- Floch A. Maternal Red Blood Cell Alloimmunisation Working Party, literature review. RH blood group system: rare specificities. Transfus Clin Biol 2021;28:314–20.
- Pegoraro V, Urbinati D, Visser GHA, et al. Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: a preventable disease that still produces significant morbidity and mortality in children. PLoS One 2020;15:e0235807.
- Gudlaugsson B, Hjartardottir H, Svansdottir G, et al. Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis. Transfusion 2020;60:175–83.
- Dajak S, Stefanović V, Capkun V. Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first–trimester screening (CME). Transfusion 2011;51:1380–8.
- Turley E, McGowan EC, Hyland CA, et al. Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31). Transfusion 2018;58:2260–4.
- Bub CB, Aravechia MG, Costa TH, Kutner JM, Castilho L. RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization. J Clin Lab Anal 2018;32:e22221.
- Lukacevic Krstic J, Dajak S, Bingulac-Popovic J, Dogic V, Mratinovic-Mikulandra J. Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population. J Clin Lab Anal 2018;32:e22285.
- Quantock KM, Lopez GH, Hyland CA, et al. Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn. Transfusion 2017;57:1938–43.
- Duncan JA, Nahirniak S, Onell R, Clarke G. Two cases of the variant RHD*DAU5 allele associated with maternal alloanti-D. Immunohematology 2017;33:60–3.
- Lukacevic Krstic J, Dajak S, Bingulac-Popovic J, Dogic V, Mratinovic-Mikulandra J. Anti-D antibodies in pregnant D variant antigen carriers initially typed as RhD. Transfus Med Hemother 2016;43:419–24.
- Sandler SG, Flegel WA, Westhoff CM, et al. It’s time to phase in RHD genotyping for patients with a serologic weak D phenotype: College of American Pathologists Transfusion Medicine Resource Committee Work Group. Transfusion 2015;55:680–9.
- Flegel WA, Denomme GA, Queenan JT, et al. It’s time to phase out “serologic weak D phenotype” and resolve D types with RHD genotyping including weak D type 4. Transfusion 2020;60:855–9.
- Sandler SG, Chen LN, Flegel WA. Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype. Br J Haematol 2017;179:10–9.
- Wagner FF, Flegel WA. The Rhesus Site. Transfus Med Hemother 2014;41:357–63.
- Storry JR, Clausen FB, Castilho L, et al. International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: Report of the Dubai, Copenhagen and Toronto meetings. Vox Sang 2019;114:95–102.
- Flegel WA. Proceed with care: the “uncommon” serologic weak D phenotypes. Blood Transfus 2021;19:272–6.
- International Society of Blood Transfusion. Names for RHD (ISBT 004) Blood Group Alleles (ISBT_004__RHD_blood_ group_alleles_v6.0_30–NOV–2021.pdf).
https://www. isbtweb.org/resource/004rhd.html . Accessed 2 February 2022. - Wagner FF, Frohmajer A, Ladewig B, et al. Weak D alleles express distinct phenotypes. Blood 2000;95:2699–708.
- Wagner FF, Ladewig B, Angert KS, Heymann GA, Eicher NI, Flegel WA. The DAU allele cluster of the RHD gene. Blood 2002;100:306–11.
- Flegel WA, von Zabern I, Doescher A, et al. D variants at the RhD vestibule in the weak D type 4 and Eurasian D clusters. Transfusion 2009;49:1059–69.
- Hemker MB, Ligthart PC, Berger L, van Rhenen DJ, van der Schoot CE, Wijk PA. DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks. Blood 1999;94:4337–42.
- Yu X, Wagner FF, Witter B, Flegel WA. Outliers in RhD membrane integration are explained by variant RH haplotypes. Transfusion 2006;46:1343–51.
- Horuk R, Martin AW, Wang Z, et al. Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 1997;158:2882–90.
- Huh JY, Park G, Jang SJ, Moon DS, Park YJ. A rapid long PCR-direct sequencing analysis for ABO genotyping. Ann Clin Lab Sci 2011;41:340–5.
- Wagner FF, Gassner C, Müller TH, Schönitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood 1999;93:385–93.
- Fasano RM, Monaco A, Meier ER, et al. RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management. Blood 2010;116:2836–8.
- Ouchari M, Srivastava K, Döscher A, et al. Serologic and molecular characterization of weak D type 29. Transfusion 2017;57:2542–4.
- Wagner FF, Flegel WA. RHD gene deletion occurred in the Rhesus box. Blood 2000;95:3662–8.
- Srivastava K, Polin H, Sheldon SL, et al. The DAU cluster: a comparative analysis of 18 RHD alleles, some forming partial D antigens. Transfusion 2016;56:2520–31.
- Flegel WA, Gassner C, Muller TH, Schonitzer D, Schunter F, Wagner FF. The molecular basis of weak D (abstract). Vox Sang 1998;74:15.
- Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet 2001;2:10.
- Wolinsky H. A mythical beast: increased attention highlights the hidden wonders of chimeras. EMBO Rep 2007;8:212–4.
- Körmöczi GF, Dauber EM, Haas OA, et al. Mosaicism due to myeloid lineage restricted loss of heterozygosity as cause of spontaneous Rh phenotype splitting. Blood 2007;110: 2148–57.
- Dauber EM, Mayr WR, Hustinx H, et al. Somatic mosaicisms of chromosome 1 at two different stages of ontogenetic development detected by Rh blood group discrepancies. Haematologica 2019;104:632–8.
- Lin JJ, Wang XD, Zhu SY. α-1,3-N-acetylgalactose aminotransferase gene 539G>C mutation leads to the A2B isoform. Genet Mol Res 2014;13:2987–93.
- Reiss RF, Malavade V, Johnson CL, Hendricks E, Rabin BI, Marsh WL. Blood grouping with the Olympus PK7100 testing system. Clin Lab Haematol 1988;10:385–90.
- Saboor M, Zehra A, Hamali HA, et al. Prevalence of A(2) and A(2)B subgroups and anti–A(1) antibody in blood donors in Jazan, Saudi Arabia. Int J Gen Med 2020;13:787–90.
- Klein HG, Anstee DJ, Eds. ABO, H, LE, P1PK, GLOB, I and FORS blood group systems. In: Mollison’s blood transfusion in clinical medicine. 12th ed. Oxford: Blackwell Publishing Ltd., 2014:121.
- International Society of Blood Transfusion. Names for ABO (ISBT 001) Blood Group Alleles (001_ABO_Alleles_v1.2.pdf).
https://www.isbtweb.org/resource/001aboalleles.html . Accessed 2 February 2022. - Reyes F, Gourdin MF, Lejonc JL, Cartron JP, Gorius JB, Dreyfus B. The heterogeneity of erythrocyte antigen distribution in human normal phenotypes: an immunoelectron microscopy study. Br J Haematol 1976;34:613–21.
- Dogic V, Bingulac-Popovic J, Babic I, et al. Distribution of weak D types in the Croatian population. Transfus Med 2011;21:278–9.
- Flegel WA, Wagner FF, Ó Donghaile DP. Anti-D immunization rates may exceed 50% in many clinically relevant settings, despite varying widely among patient cohorts. Transfusion 2020;60:1109–10.
- Flegel WA. Molecular genetics and clinical applications for RH. Transfus Apher Sci 2011;44:81–91.
- Cornish VW, Kaplan MI, Veenstra DL, Kollman PA, Schultz PG. Stabilizing and destabilizing effects of placing beta-branched amino acids in protein alpha-helices. Biochemistry 1994;33:12022–31.
- Bruce LJ, Ghosh S, King MJ, et al. Absence of CD47 in protein 4.2-deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complex. Blood 2002;100:1878–85.
- Dahl KN, Parthasarathy R, Westhoff CM, Layton DM, Discher DE. Protein 4.2 is critical to CD47-membrane skeleton attachment in human red cells. Blood 2004;103:1131–6.
- Nicolas V, Le Van Kim C, Gane P, et al. Rh-RhAG/ankyrin-R, a new interaction site between the membrane bilayer and the red cell skeleton, is impaired by Rh(null)-associated mutation. J Biol Chem 2003;278:25526–33.
- Luettringhaus TA, Cho D, Ryang DW, Flegel WA. An easy RHD genotyping strategy for D– East Asian persons applied to Korean blood donors. Transfusion 2006;46:2128–37.
- Denomme GA, Dake LR, Vilensky D, Ramyar L, Judd WJ. Rh discrepancies caused by variable reactivity of partial and weak D types with different serologic techniques. Transfusion 2008;48:473–8.
- Tammi SM, Tounsi WA, Sainio S, et al. Next-generation sequencing of 35 RHD variants in 16 253 serologically D– pregnant women in the Finnish population. Blood Adv 2020;4:4994–5001.
- de Moura Neto JP, Cerqueira BAV, Santos WVB, Lyra IM, Goncalves MS. The DAU allele and anti-D alloimmunization present with high frequency in Brazilian sickle cell disease patients. J Hematol 2017;6:73–80.
- Karnot A, Woestmann SJ, Flesch BK. Weak RhD phenotype caused by compound heterozygosity for DAU-2 and a new RHD*c393-394 dupGG-mutation (abstract). Transfus Med Hemother 2016;43:42–3.
- Wagner FF, Moulds JM, Tounkara A, Kouriba B, Flegel WA. RHD allele distribution in Africans of Mali. BMC Genet 2003;4:14.
- Kulkarni SS, Gogri H, Parchure D, et al. RHD–positive alleles among D– C/E+ individuals from India. Transfus Med Hemother 2018;45:173–7.
- Fichou Y, Le Maréchal C, Bryckaert L, et al. A convenient qualitative and quantitative method to investigate RHD-RHCE hybrid genes. Transfusion 2013;53:2974–82.
- Heilig EA, Gutti U, Tai T, Shen J, Kelleher RJ 3rd. Trans-dominant negative effects of pathogenic PSEN1 mutations on γ-secretase activity and Aβ production. J Neurosci 2013;33:11606–17.